Seaport Therapeutics reports positive phase 1 results for anxiety drug

April 2, 2026 7:08 AM

Seaport Therapeutics announced positive results from its ongoing Phase 1 trial of GlyphAgo, an experimental treatment for generalized anxiety disorder ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found